Bone Margin Analysis for Benign Odontogenic Tumors.
With the potential exception of the case of ameloblastoma, information relevant to the exact tumor-bone interface and extent of bone invasion by the commonly encountered odontogenic tumors is lacking. These tumors are rare. Treatment rendered varies significantly. Although commonly accepted practices are recommended, scientific evidence is relatively lacking. Prospective multicenter studies from tertiary treatment centers are required for evidence-based guidelines. Until studies are available, the proposed linear bone resection margin for odontogenic tumors and the evaluation of its adequacy in tumor eradication will be based on the limited data available.